Pfizer Signs a New Agreement With Callidus Software
World's Largest Biopharmaceutical to Deploy Sales Enablement in the Cloud
(firmenpresse) - PLEASANTON, CA -- (Marketwire) -- 09/14/11 -- Callidus Software Inc. (NASDAQ: CALD), the leader in , announced today that Pfizer Inc, the world's largest research-based biopharmaceutical company, has selected the iCentera Sales Enablement SaaS platform to drive the effectiveness of its sales team in the U.S., including internal sales, contract sales, and channel partners. The agreement was signed in the third quarter of 2011.
"At Pfizer, we need to effectively drive a targeted, relevant value proposition across a large portfolio of products," said Jeffrey LiPira, Director, Team Leader Sales Operations, Pfizer. "With the iCentera Sales Enablement solution, we can deliver targeted product information in real-time across our broad-based, distributed sales network and increase our sales force productivity through more knowledgeable sales people."
"Today's sales force demands a platform that helps them determine on-the-fly the right value proposition for the customer," said Craig Nelson, Vice President, Sales Enablement, Callidus Software. "The iCentera Sales Enablement solution is a SaaS and mobile-based platform that equips sales professionals with up-to-date, audience-relevant information. The platform enables sales to leverage subject matter experts and best practices to convey value for any product throughout the buying process. With iCentera, businesses can ensure that their teams have the right content, tools, and resources for each buyer to help them drive customer value and win."
is the leading provider of SaaS-based sales enablement solutions. iCentera's patented platform replaces static portals with a single sales enablement system that quickly enables business users to create and distribute marketing content to sales teams, partners, and customers. The iCentera platform provides easy-to-use solutions for business users that incorporate automated content management, portal creation, and built-in trend and behavior analytics through a cost-effective implementation that is running and available within days. In addition, the iCentera Mobile and integrated collaboration platform enables sales users to access subject matter experts and best practices when they need it most -- when selling.
"The Callidus Cloud platform has delivered real business benefits at Pfizer, enabling them to increase their sales effectiveness across their sales network," said Andrew Hahn, Vice President, CallidusRX, Callidus Software. "This new contract further extends our partnership and we look forward to working with Pfizer as they continue to build on their sales success."
iCentera Sales Enablement is delivered as part of Callidus Cloud. Callidus Software's Cloud is a comprehensive designed to help businesses drive more effective selling from improved sales hiring -- the foundation of strong sales performance -- to improved campaign execution, to high frequency coaching and development. The Callidus Cloud suite includes Callidus' 100% multi-tenant, high-availability SaaS infrastructure; its Sales Selection, Sales Effectiveness, Sales Performance, and Learning modules; SPMConnect for data management; and Reporting & Analytics. Callidus Software powers more than 2.5 million users across the globe.
Follow our blog, join us on and or follow us on for real-time updates.
At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals. Our diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many of the world's best-known consumer products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as the world's leading biopharmaceutical company, we also collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. To learn more about our commitments, please visit us at .
iCentera is sales enablement, with the industry's most advanced yet affordable hosted Sales Enablement Platform to drive knowledge transfer from marketing resources to sales teams, partners and customers. iCentera's patented platform replaces static sales, partner, and customer portals with a single sales enablement system that adapts to the needs of each user. Customers include NetApp, NBA, TransUnion, Thomson Reuters, Adobe and Solta Medical. To discover why more than 180,000 subscribers leverage iCentera to optimize their sales enablement ROI, drive efficient revenue growth, and achieve a perfectly consistent marketing voice across their entire company ecosystem, please visit us at or . iCentera is a Callidus Software Inc. (NASDAQ: CALD) company.
Callidus Software (NASDAQ: CALD) is the market and technology leader in (SPM). Callidus award-winning SaaS platform -- the Callidus Cloud -- is a comprehensive SaaS suite designed to help businesses drive more effective selling at each stage of the sales talent lifecycle, from improved sales hiring -- the foundation of strong sales performance -- to improved campaign execution, to high frequency coaching and development. The Callidus Cloud suite includes Callidus' 100% multi-tenant, high-availability SaaS infrastructure; its Sales Selection, Sales Effectiveness, Sales Performance, and Learning modules; SPMConnect for data management; and Reporting & Analytics. Callidus Software powers more than 2.5 million users across the globe. For more information, please visit .
©1997-2011 Callidus Software Inc. All rights reserved. Callidus Software, the Callidus Software logo, TrueComp Manager, ActekSoft and ACom3 are trademarks, service marks, or registered trademarks of Callidus Software Inc. in the United States and other countries. All other brand, service or product names are trademarks or registered trademarks of their respective companies or owners.
Press Contact:
Rajendran Nair
Callidus Software, Inc.
925-251-2255
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 14.09.2011 - 11:00 Uhr
Sprache: Deutsch
News-ID 65747
Anzahl Zeichen: 0
contact information:
Town:
PLEASANTON, CA
Kategorie:
Internet
Diese Pressemitteilung wurde bisher 302 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Pfizer Signs a New Agreement With Callidus Software"
steht unter der journalistisch-redaktionellen Verantwortung von
Callidus Software Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
